Skin Barrier-Informed Topical and Transdermal Drug Delivery: Excipient-Driven Strategies, Vehicle Transformation, and Translational Challenges
Pharmaceutics · 26.08.2026 · 18 (9) · 1069
DOI: 10.3390/pharmaceutics18091069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 26.08.2026. Verfasst von Binaya Sapkota und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Mu…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 292 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, Ministry of Education, Korean government.
Abstract (Originalsprache)
Topical and transdermal dosage forms can localize therapy or provide controlled systemic exposure, but translation is limited by the selective stratum corneum (SC) barrier and post-application changes in formulation. Existing reviews often address individual enhancers or carriers without integrating drug properties, vehicle microstructure, post-application transformation, quality of evidence, and product development constraints. This review fills that gap by comparing passive formulations, chemical permeation enhancers, vesicular and lipid-based carriers, supersaturating systems, and physical barrier bypass technologies within a skin barrier-informed framework. Increased permeation alone does not establish translational value. Passive delivery remains most feasible for potent, moderately lipophilic small molecules. Chemical enhancers are scalable but limited by irritation and drug-dependent compatibility; nanocarriers may improve solubilization and cutaneous deposition but often lack human confirmation; and physical methods broaden delivery to macromolecules while adding device, manufacturing, usability, and regulatory burdens. Solvent evaporation, residual film composition, supersaturation, precipitation, and drug–vehicle affinity further determine the effective post-application driving force. Accordingly, we propose an evidence-ranked framework linking payload properties and target compartment to mechanism, safety, clinical readiness, and regulatory complexity. It distinguishes mechanistic promise from clinically demonstrated delivery and identifies the evidence needed to advance reproducible topical and transdermal products.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Muan-gun 58554, Jeonnam, Republic of Korea.
- College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun 58554, Jeonnam, Republic of Korea.
- Biomedicine Cutting Edge Formulation Technology Center, Mokpo National University, Muan-gun 58554, Jeonnam, Republic of Korea.
ORCID-Profile: Susmita Phuyal, Arjun Dhwoj Bamjan, Seung-Sik Cho, Jung-Hyun Shim, Jin Woo Park, Laxman Subedi
Förderung
- Ministry of Science and ICT
- Ministry of Education
- Korean government
- Ministry of Education (MOE) and the Jeonnam-Gwangju Special Metropolitan City, Republic of Korea
Zitieren
APA
Sapkota, B., Phuyal, S., Bamjan, A. D., Cho, S. S., Shim, J. H., Park, J. W., & Subedi, L. (2026). Skin Barrier-Informed Topical and Transdermal Drug Delivery: Excipient-Driven Strategies, Vehicle Transformation, and Translational Challenges. Pharmaceutics, 18(9), 1069. https://doi.org/10.3390/pharmaceutics18091069
Vancouver
Sapkota B, Phuyal S, Bamjan AD, Cho SS, Shim JH, Park JW, et al. Skin Barrier-Informed Topical and Transdermal Drug Delivery: Excipient-Driven Strategies, Vehicle Transformation, and Translational Challenges. Pharmaceutics. 2026;18(9):1069. doi:10.3390/pharmaceutics18091069
BibTeX
@article{Sapkota2026,
author = {Sapkota, Binaya and Phuyal, Susmita and Bamjan, Arjun Dhwoj and Cho, Seung-Sik and Shim, Jung-Hyun and Park, Jin Woo and Subedi, Laxman},
title = {Skin Barrier-Informed Topical and Transdermal Drug Delivery: Excipient-Driven Strategies, Vehicle Transformation, and Translational Challenges},
journal = {Pharmaceutics},
year = {2026},
volume = {18},
number = {9},
pages = {1069},
doi = {10.3390/pharmaceutics18091069}
}
EUVIMED